Reactivation of Hepatitis B after Administration of Anti-TNF<i>α</i> in a Patient with Psoriasis

ISSN Print: 2158-284X
ISSN Online: 2158-2882
www.scirp.net/journal/ijcm
E-mail: [email protected]

Citations

"Reactivation of Hepatitis B after Administration of Anti-TNFα in a Patient with Psoriasis"
written by Tania Díaz Corpas, Almudena Mateu Puchades, Ana Zayas Gavilá, Amparo Marquina Vila,
published by International Journal of Clinical Medicine, Vol.3 No.2, 2012

has been cited by the following article(s):

[1]	Safety of therapies using ustekinumab in patients with psoriasis who have had hepatitis B virus infection
	Dermatologic …, 2022

[2]	Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab
	Clinical Drug Investigation, 2018

[3]	New therapies versus first-generation biologic drugs in psoriasis: a review of adverse events and their management
	Expert Review of Clinical Immunology, 2018

[4]	Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature
	Journal of the American Academy of Dermatology, 2017

[1]	Safety of therapies using ustekinumab in patients with psoriasis who have had hepatitis B virus infection Dermatologic Therapy, 2022 DOI:10.1111/dth.15274

[2]	New therapies versus first-generation biologic drugs in psoriasis: a review of adverse events and their management Expert Review of Clinical Immunology, 2018 DOI:10.1080/1744666X.2018.1454835

[3]	Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab Clinical Drug Investigation, 2018 DOI:10.1007/s40261-018-0671-z

[4]	Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature Journal of the American Academy of Dermatology, 2017 DOI:10.1016/j.jaad.2017.01.037